UK govt pledges £260m to health data, manufacturing

March 4, 2022

The UK biopharma industry has welcomed a new tranche of funding from the government aimed at bolstering manufacturing of medicinal products and developing the national health data infrastructure.

The investment package includes £200 million ($268 million) to enable researchers to better access NHS data through what the government calls Trusted Research Environments and digital clinical trial services.

Read the source article at pharmaphorum.com
2022-03-03 10:46:07

Share This Story!